<DOC>
	<DOCNO>NCT00469781</DOCNO>
	<brief_summary>The objective study determine twice-daily dose prednisolone ( Pred Forte ) effective four-times-daily dose prednisolone prevention retinal thickening cystoid macular edema ( CME ) either regimen use concomitantly twice-daily bromfenac .</brief_summary>
	<brief_title>Bromfenac BID Plus Prednisolone Acetate BID Versus Bromfenac BID Plus Prednisolone QID Prevention Cystoid Macular Edema Retinal Thickening</brief_title>
	<detailed_description />
	<mesh_term>Macular Edema</mesh_term>
	<mesh_term>Edema</mesh_term>
	<mesh_term>Prednisolone acetate</mesh_term>
	<mesh_term>Bromfenac</mesh_term>
	<mesh_term>Prednisolone</mesh_term>
	<criteria>· Male female &gt; 18 year age schedule undergo cataract surgery Must good general health . Patients systemic disease enrol ocular manifestation disease ( ie diabetic normal retinal exam ) Expected visual outcome 20/25 better . Ability provide inform consent likely complete study visit · Known contraindication study medication component Uncontrolled systemic disease Required use ocular medication study medication study Abnormal preoperative OCTs Diabetic patient history macular edema diabetic retinopathy AMD , epiretinal membrane , retinal vein occlusion , preexist macular disease Only one eye patient enrol</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2008</verification_date>
</DOC>